drug resistance surveillance: current status and latest ...€¦ · usaid, the global fund, pepfar,...
TRANSCRIPT
![Page 1: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/1.jpg)
Drug resistance surveillance:
current status and latest innovations
45th Union World Conference on Lung Health
(WHO satellite meeting)
29 October 2014, Barcelona, Spain
Anna Dean ([email protected])
![Page 2: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/2.jpg)
Objectives:
� To estimate the magnitude of drug resistance
� To determine trends in drug resistance over time
Main technical partners:
� Project hosted by WHO
� Supranational TB Reference Laboratories (SRLs),
The Union, US CDC, KNCV, ECDC,
RIT-Japan
Main donor Agencies:
� USAID, The Global Fund, PEPFAR, BMGF
20 YEAR ANNIVERSARY (1994-2014) Global project on anti-TB drug resistance surveillance
![Page 3: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/3.jpg)
The SRL Network
![Page 4: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/4.jpg)
1. Coverage of surveillance
2. Latest surveillance data
3. Visions for the future
![Page 5: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/5.jpg)
1. Coverage of Surveillance
![Page 6: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/6.jpg)
1st ed. DRS
guidelines
Global
Project and
SRL
network
launched
2nd ed. DRS
guidelines
1st global
DRS report
2nd global
DRS report
3rd ed. DRS
guidelines
3rd global
DRS report
4th global
DRS report
4th ed. DRS
guidelines
M/XDR-TB
report
1994 1997 2000 2003 2004 2008 2009 2010 2014
2014 TB
report
5th ed. DRS
guidelines
under
development
The Global Project, 1994-2014
![Page 7: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/7.jpg)
Progress in global coverage of surveillance data on
drug resistance, 1994-2014
144
![Page 8: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/8.jpg)
Progress in global coverage of surveillance data on
drug resistance, 1994-2014
![Page 9: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/9.jpg)
Number of national drug resistance surveillance country-year data points, 1994-2014
![Page 10: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/10.jpg)
2. Latest surveillance data
![Page 11: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/11.jpg)
Current MDR-TB situation
![Page 12: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/12.jpg)
Proportion of new TB cases with MDR-TB, 2014
GLOBAL: 3.5%
EURO: 14%
![Page 13: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/13.jpg)
Proportion of previously treated TB cases
with MDR-TB, 2014
GLOBAL: 20.5%
EURO: 44%
![Page 14: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/14.jpg)
Proportion of all TB cases with resistance to isoniazid but not rifampicin, 1994-2014
9.5%
![Page 15: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/15.jpg)
Countries that notified at least one case of
XDR-TB by the end of 2013
Proportion of MDR-TB cases with XDR-TB = 9%
![Page 16: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/16.jpg)
3. Visions for the future
![Page 17: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/17.jpg)
Limitations of surveys
� Difficult to repeat at regular intervals
Limited understanding of time trends worldwide
� Surveys are mostly targeting NTP facilities
Limited understanding of drug resistance in the private
health sector
� Drug susceptibility testing limited to rifampicin and
isoniazid, plus fluoroquinolones and injectable agents on
MDR-strains
Not useful for investigating feasibility of introducing
new drugs and regimens
![Page 18: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/18.jpg)
� Incorporating molecular technologies into surveys,
including Xpert MTB/RIF and high throughput
sequencing technologies
� Expanding the range of drugs to be tested
� Establishing sentinel surveillance systems for monitoring
trends
Next steps for strengthening surveillance
![Page 19: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/19.jpg)
UPDATE: 5th edition of WHO guidelines, 2014
2009
![Page 20: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/20.jpg)
Xpert MTB/RIF in surveys
� Reduces logistic challenges for sample transport
� Reduces demands on laboratory (expertise and time)
� Limitation: depending on testing algorithm, cannot
investigate other resistance patterns not associated with
rifampicin resistance
� Used in surveys in Pakistan, Papua New Guinea, Senegal
� Planned for DR Congo, Eritrea, Ivory Coast, Zimbabwe
![Page 21: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/21.jpg)
Conventional Xpert MTB/RIF
1200-1500 cultures 100 cultures
Xpert MTB/RIF in surveys
![Page 22: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/22.jpg)
Surveillance systems for trends over time
� Indications
- For countries with recent national survey data (3-5yrs)
- To monitor trends in resistance over time
� Approach
- Sentinel sites chosen purposively, unlike national surveys
- Testing of consecutive patients during a given time period
until target sample size is reached
- Repeated annually
- Rapid molecular technologies
� Limitations
- Data are not nationally representative
- Data cannot be extrapolated to other areas
![Page 23: Drug resistance surveillance: current status and latest ...€¦ · USAID, The Global Fund, PEPFAR, BMGF 20 YEAR ANNIVERSARY (1994 -2014) Global project on anti-TB drug resistance](https://reader033.vdocuments.us/reader033/viewer/2022051810/601b2d538ef294321b6891d0/html5/thumbnails/23.jpg)
Conclusions
� Require more country-specific drug resistance
surveillance data (more countries, more drugs, more data
points)
� Need to trial new approaches to surveillance in drug
resistance (particularly to assess time trends and burden
of drug resistance in the private health sector)
� Increase reliance on molecular technologies